Evidence map›Paper›PMID 38609702›Full record

ArticlePediatric radiology2024

Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study.

Justine N van der Beek, Jens-Peter Schenk, Carlo Morosi, Tom A Watson, Ana Coma, Norbert Graf, Tanzina Chowdhury, Gema L Ramírez-Villar, Filippo Spreafico, Nils Welter and 5 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Pediatric radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 5 countries.

Justine N van der BeekDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. j.n.vanderbeek-6@umcutrecht.nl.ORCID 0000-0002-4798-8787
Jens-Peter SchenkClinic of Diagnostic and Interventional Radiology, Division of Pediatric Radiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-0588-0225
Carlo MorosiDepartment of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID 0000-0003-4940-2185
Tom A WatsonDepartment of Paediatric Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID 0000-0001-6079-3362
Ana ComaDepartment of Pediatric Radiology, Hospital Vall d'Hebron, Barcelona, Spain.ORCID 0000-0001-8290-9717
Norbert GrafDepartment of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.ORCID 0000-0002-2248-323X
Tanzina ChowdhuryDepartment of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID 0000-0003-3891-5778
Gema L Ramírez-VillarDepartment of Paediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID 0000-0001-9986-5861
Filippo SpreaficoPediatric Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID 0000-0002-5587-3509
Nils WelterDepartment of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.ORCID 0000-0001-9874-4726
Kristina DzhumaDevelopmental Biology and Cancer Department, University College London Great Ormond Street Institute of Child Health, London, UK.ORCID 0000-0003-4559-3252
Harm van TinterenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0002-4626-8702
Ronald R de KrijgerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0001-6871-1296
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0002-7760-879X
Annemieke S LittooijDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.ORCID 0000-0002-1839-0882
Great Ormond Street Hospital for Children NHS Foundation Trust · GBUtrecht University · NLFondazione IRCCS Istituto Nazionale dei Tumori · ITSaarland University · DEHeidelberg University · DEHospital Universitario Virgen del Rocío · ESPrincess Máxima Center · NLUniversity Medical Center Utrecht · NLVall d'Hebron Hospital Universitari · ES

Funding

Stichting Kinderen Kankervrij 341
6 · The paper itself

Abstract

backgroundCongenital mesoblastic nephroma is the most common solid renal tumor in neonates. Therefore, patients <3 months of age are advised to undergo upfront nephrectomy, whereas invasive procedures at diagnosis in patients ≥3 months of age are discouraged by the International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG). Nevertheless, discriminating congenital mesoblastic nephroma, especially from the more common Wilms tumor, solely based on imaging remains difficult. Recently, magnetic resonance imaging (MRI) has become the preferred modality. Studies focusing on MRI characteristics of congenital mesoblastic nephroma are limited.

objectiveThis study aims to identify diagnostic MRI characteristics of congenital mesoblastic nephroma in the largest series of patients to date. MATERIALS AND

methodsIn this retrospective multicenter study, five SIOP-RTSG national review radiologists identified 52 diagnostic MRIs of histologically proven congenital mesoblastic nephromas. MRI was performed following SIOP-RTSG protocols, while radiologists assessed their national cases using a validated case report form.

resultsPatients (24/52 classic, 11/52 cellular, and 15/52 mixed type congenital mesoblastic nephroma, 2/52 unknown) had a median age of 1 month (range 1 day-3 months). Classic type congenital mesoblastic nephroma appeared homogeneous with a lack of hemorrhage, necrosis and/or cysts, showing a concentric ring sign in 14 (58.3%) patients. Cellular and mixed type congenital mesoblastic nephroma appeared more heterogeneous and were larger (311.6 and 174.2 cm

conclusionThis retrospective international collaborative study showed classic type congenital mesoblastic nephroma predominantly presented as a homogeneous T2-weighted isointense mass with a typical concentric ring sign, whereas the cellular type appeared more heterogeneous. Future studies may use identified MRI characteristic of congenital mesoblastic nephroma for validation and for exploring the discriminative non-invasive value of MRI, especially from Wilms tumor.

Indexed as

Kidney NeoplasmsMagnetic Resonance ImagingNephroma, MesoblasticDiagnosis, DifferentialFemaleHumansInfantInfant, NewbornMaleRetrospective StudiesCongenital mesoblastic nephromaKidney neoplasmsMagnetic resonance imagingPediatricsRadiologyWilms tumor

Identifiers

PMID38609702
PMCPMC11111520
OpenAlexW4394768902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.